Scientists solve decades-long Parkinson’s mystery
On Mar. 14, 2025, researchers from the Walter and Eliza Hall Institute of Medical Research (WEHI) announced they…
On Mar. 14, 2025, researchers from the Walter and Eliza Hall Institute of Medical Research (WEHI) announced they…
On Mar. 11, 2025, researchers at St Vincent’s Hospital Sydney announced the first implant of a BiVACOR Total…
On Jan. 29, 2025, researchers at The University of Queensland announced they have identified the first henipavirus in…
On Jan. 9, 2025, clinicians from the The University of Queensland (UQ) announced they had successfully used custom-made…
On Jan. 7, 2025, scientists at The University of Queensland (UQ) and the University of Sydney announced they…
On Dec. 19, 2024, a University of Queensland (UQ) study has found no link between exposure to water…
On Dec. 18, 2024, BiVACOR, a clinical-stage medical device company, announced the successful completion of the first phase…
On Dec. 17, 2024, scientists at The University of Queensland (UQ) announced they had licensed a promising ultrasound…
On Dec. 5, 2024, researchers Dr Sonia Shah and Dr Clara Jiang from the University of Queensland’s Institute…
On Nov. 11, 2024, an international team of researchers has for the first time cured patients with Toxic…
On Oct. 17, 2024, Colossal Biosciences, an American biotechnology and genetic engineering company, announced that it has a…
On Oct. 8, 2024, scientists from the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency,…
On Jul. 25, 2024, doctors from the Texas Heart Institute (THI), BiVACOR®, Baylor St. Luke’s Medical Center and…
On May 22, 2024, the World Health Organization (WHO) announced that the first confirmed case of human infection…
On Mar. 4, 2024, Hugel America announced it received U.S. Food and Drug Administration (FDA) approval on its…
On Feb. 16, 2024, the Australian Government announced it had issued QUT a licence to commercially release QCAV-4,…
On Dec. 7, 2023, BioNTech announced that it had signed a multi-year strategic partnership with the State of…
On Feb. 28, 2023, a team from the University of Sydney reported that a flu virus found in…
On Nov. 1, 2022, the Medicines Control Authority of Zimbabwe announced that it had approved the use of…
On Sept. 1, 2022, Novavax announced that Nuvaxovid (NVX-CoV2373) COVID-19 vaccine had been recommended for expanded conditional marketing…
On Aug. 29, 2022, a group of international researchers, coordinated by Dr Jo�o Teixeira at The Australian National…
On Jul. 26, 2022, Novavax announced that the Australian Therapeutic Goods Agency had granted expanded approval for provisional…
On Jul. 18, 2022, Moderna announced that the Therapeutic Goods Administration (TGA) in Australia had granted provisional registration…
On Jun. 13 2022, Novavax announced that the Australian Therapeutic Goods Administration (TGA) had granted provisional registration of…
On Jun. 2, 2022, Novavax announced the submission of a request to the Medicines and Healthcare products Regulatory…
On May 21, 2022, the World Health Organization (WHO) reported that since May 13, 2022, cases of mpox…
On May 6, 2022, Novavax announced the submission of variations to the Australian Therapeutic Goods Agency (TGA) and…
On Mar. 23, 2022, Moderna announced the finalization of a strategic partnership with the Australian Federal Government to…
On Mar. 17, 2022, Moderna announced that Health Canada had approved the use of Moderna’s mRNA COVID-19 vaccine,…
On Feb. 23, 2022, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…